Pharnext (XPAR:ALPHA) Short-Term Debt : €0.00 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharnext Short-Term Debt?

Pharnext's Short-Term Debt for the quarter that ended in Dec. 2023 was €0.00 Mil.

Pharnext's quarterly Short-Term Debt declined from Dec. 2022 (€3.31 Mil) to Jun. 2023 (€0.63 Mil) and declined from Jun. 2023 (€0.63 Mil) to Dec. 2023 (€0.00 Mil).

Pharnext's annual Short-Term Debt declined from Dec. 2021 (€8.71 Mil) to Dec. 2022 (€3.31 Mil) and declined from Dec. 2022 (€3.31 Mil) to Dec. 2023 (€0.00 Mil).

Pharnext Short-Term Debt Historical Data

The historical data trend for Pharnext's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharnext Short-Term Debt Chart

Pharnext Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

3.81

3.93

8.71

3.31

Pharnext Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															8.71	11.28	3.31	0.63	-

Pharnext Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Pharnext Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Pharnext's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharnext (XPAR:ALPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

P0X0:Germany

Address

11-13 Rue Rene Jacques, Issy-Les-Moulineaux, FRA, 92130

Website

http://www.pharnext.com

Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.

Pharnext (XPAR:ALPHA) Headlines

No Headlines